Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects

Aim Venadaparib is a next-generation poly(ADP-ribose) polymerase inhibitor under development for treating gastric cancer. This study aimed to evaluate the effects of food and ethnicity on the pharmacokinetics (PKs) and safety of venadaparib after a single oral administration in healthy Korean, Cauca...

Full description

Saved in:

Bibliographic Details
Published in:	Investigational new drugs Vol. 42; no. 1; pp. 80 - 88
Main Authors:	Kim, Hyun Chul, Yang, Eunsol, Lee, Soyoung, Oh, Jaeseong, Lee, Myongjae, Lee, ChaeEun, Ha, Kyoung Soo, Lee, Won Sik, Jang, In-Jin, Yu, Kyung-Sang
Format:	Journal Article
Language:	English
Published:	New York Springer US 01.02.2024 Springer Nature B.V
Subjects:	Dosage Ethnicity Food Gastric cancer Inhibitors Labels Males Medicine Medicine & Public Health Minority & ethnic groups Oncology Oral administration Pharmacokinetics Pharmacology/Toxicology Poly(ADP-ribose) Poly(ADP-ribose) polymerase Ribose Statistical analysis Targeted cancer therapy Time measurement White people Ethnic effect Food effect Pharmacokinetics PARP inhibitor Venadaparib
ISSN:	0167-6997, 1573-0646, 1573-0646
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!